Inequalities in Pap smear screening for cervical cancer in Brazil.
HPV vaccine programs in Latin America run the risk of repeating the problems associated with Papanicolaou (Pap) test programs, an efficient, life-saving tool that is unfortunately underutilized for cancer prevention, in low- and middle-income countries. There is a great need for vigilance in the ongoing implementation of the HPV vaccine in Latin America.
Social and economic impact of cervical cancer in Brazil: analysis of EVA/EVITA cohort study (LACOG 0215)
Angelica Nogueira-Rodrigues, Andréia Cristina de Melo, Aknar Freire de Carvalho Calabrich, Eduardo Cronenberger, Kátia Luz Torres, Fernanda Damian, Rachel Cossetti, Carla Rameri A. S. De Azevedo, Allex Jardim da Fonseca, Yeni Nerón, João Nunes, André Lopes, Felipe Thomé, Renato Leal, Giuliano Borges, Paulo Ricardo Santos Nunes Filho, Facundo Zaffaroni, Leissa Hertzog, Rafaela Gomes de Jesus, Gustavo Werutsky e Fernando Maluf IGCS 2019; 42, oral presentation Full link: https://ijgc.bmj.com/content/29/Suppl_3/A25.2.abstract
HPV Vaccination in Latin America: Global Challenges and Feasible Solutions
Angelica Nogueira-Rodrigues
Quality of life in newly diagnosed patients with cervical cancer in Brazil: results of EVITA study (EVA/LACOG 0215).
Angelica Nogueira Rodrgiues, Aknar Calabrich, Eduardo Cronemberger, Kátia Luz, Torres, Fernanda Damian, Rachel Jorge Dino Cossetti, Carla Rameri Alexandre Silva De Azevedo, Allex Jardim da Fonseca, Yeni Verónica Neron, Joao Soares Nunes, André Lopes, Felipe Thome, Renato Leal, Giuliano Santos Borges, Paulo Ricardo Santos Nunes Filho, Facundo Zaffaroni, Gustavo Werutsky, Fernando C. Maluf Annals of Oncology (2018) 29 (suppl_8): viii332-viii358. 10.1093/annonc/mdy285 Full link: https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/Quality-of-life-in-newly-diagnosed-patients-with-cervical-cancer-in-Brazil-results-of-EVITA-study-EVA-LACOG-0215
Association of age, race, and public health insurance with stage of cervical cancer at diagnosis in Brazil: Results of the EVITA cohort study (LACOG0215)
A. N. Rodrigues, A. C. de Melo, A. Calabrich, E. Cronemberger, K. L. Torres, F. Damian, R. J. Leal, C. Rameri, A. Azevedo, A. Fonseca, Y. Neron, J. Nunes, A. Lopes, F. Thome, R. Leal, G. Borges, P. Nunes Filho, F. Zaffaroni, G. Werutsky, F. C. Maluf PMID: 22742058 PMCID: PMC3482026 DOI: 10.2105/AJPH.2011.300532 Full link: http://abstracts.asco.org/214/AbstView_214_219975.html
Social disparities and patients’ attitudes are associated with lower rates of cervical cancer screening in Brazil: Results of EVITA study (LACOG 0215).
A. N. Rodrigues, A. de Melo, A. Calabrich, E. Cronemberger, K. Torres, F. Damian, R. C. Leal, C. Rameri, A. De Azevedo, A. da Fonseca, Y. Neron, J. S. Nunes, A. Lopes, F. Thome, R. Leal, G. Borges, A. F. da Silva, M. F. Rodrigues, F. Zaffaroni, G. Werutsky, F. C. Maluf ASCO 2018 Full link: https://meetinglibrary.asco.org/record/163812/abstract
Exploiting HPV-induced carcinogenesis for a rational drug development in cervical cancer.
Nogueira-Rodrigues A, Melo AC, Werutsky G, Garces AH, Ferreira CG.
Inequities in Pap smear screening for cervical cancer between Brazilian urban and rural populations.
Jeovany Martínez-Mesa, Gustavo Werutsky, Carlos Alberto Sampaio-Filho, Aknar Calabrich, Carlos H. BarriosJ Clin Oncol 31, 2013 (suppl; abstr e12510) Full link: https://meetinglibrary.asco.org/record/82753/abstract